ImmuSAFE™ is a novel, lab-based biochip test for COVID-19 that enables highly quantitative determination of both level and target locations of SARS-CoV-2 antibodies in an individual.
The test will be able to:
Scenario 1- suspected COVID-19 positive individual
Scenario 2- following COVID-19 vaccination
Accurate determination of the antibody levels produced at different stages following an infection is key to understanding the level and prevalence of neutralizing antibodies.
ImmuSAFE® has identified 6 different functional domains of the Nucleocapsid protein, and 3 different functional domains of the Spike protein.
What are protective antibodies?
Protective antibodies (or neutralizing antibodies) defend your body from viruses and stops the spread of the virus. It is produced as part of your immune response from being infected or vaccinated.